Cancer vaccines from research to clinical practice / edited by Adrian Bot, Mihail Obrocea, and Francesco Marincola.
Contributor(s): Bot, Adrian | Marincola, Francesco M | Obrocea, Mihail.
Publisher: New York : Informa Healthcare, 2011Description: 280 p: illustrations.ISBN: 9781138112605.Subject(s): Cancer vaccinesGenre/Form: Print books.| Current location | Call number | Status | Date due | Barcode | Item holds |
|---|---|---|---|---|---|
| On Shelf | RC271.I45 C43 2011 (Browse shelf) | Available | AU00000000011632 |
Browsing Alfaisal University Shelves , Shelving location: On Shelf Close shelf browser
|
|
|
|
|
|
|
||
| RC271.C5 V53 2018 A beginner's guide to targeted cancer treatments / | RC271.D52 W53 2019 What to eat during cancer treatment / | RC271.G45 C36 2014 Cancer gene therapy by viral and non-viral vectors / | RC271.I45 C43 2011 Cancer vaccines from research to clinical practice / | RC271.I45 G73 2018 The breakthrough : immunotherapy and the race to cure cancer / | RC271.I45 K56 2019 The end of the beginning : cancer, immunity, and the future of a cure / | RC271.P33 P75 2013 Principles and practice of palliative care and supportive oncology / |
Includes bibliographical references and index.
Vaccine platforms for genito-urinary cancers, with potential applicability to other tumors -- Vaccines for solid cancers and hematological malignancies -- Vaccine development : trial design and immune assays -- Emerging new vaccine strategies, targets, and adjuvants -- Next-generation hybrid active/passive immunotherapies.
Access limited to UNC Chapel Hill-authenticated users. Unlimited simultaneous users.
"Recent advances in immunology and biology have opened new horizons in cancer therapy, included in the expanding array of cancer treatment options, which are immunotherapies, or cancer vaccines, for both solid and blood borne cancers. Cancer Vaccines: Challenges and Opportunities in Translation is the first text in the field to bring immunotherapy treatments from the laboratory trial to the bedside for the practicing oncologist. Cancer Vaccines: Challenges and Opportunities in Translation: critically analyzes the most promising classes of investigational immunotherapies, integrating their scientific rationale and clinical potential, discusses "theranostics" as pertaining to immunotherapy, i.e., using molecular diagnostics to identify patients that would most likely benefit from a therapy, presents the new paradigm of biomarker guided R&D and clinical development in immunotherapy of cancer and reviews bottlenecks in translational process of immunotherapies and offers strategies to resolve them"--Provided by publisher.
Provider: Taylor & Francis.
Vendor-supplied catalog record.